Abstract: A laminate comprising a first ply, a second ply, and a third ply which sandwiching the second ply between the first ply and the third ply. The laminate further includes a first plurality of interfacial modifiers arranged between opposing faces of the first ply and the second ply. The first plurality of interfacial modifiers are arranged in a first pattern. The laminate includes a second plurality of interfacial modifiers arranged between opposing faces of the second ply and the third ply such that the first plurality of interfacial modifiers and the second plurality of interfacial modifiers are arranged on opposite faces of the second ply. The second plurality of interfacial modifiers are arranged in a second pattern. The first pattern and the second pattern are configured to increase crack growth resistance of the laminate by selectively toughening portions of the laminate to control propagation of interfacial cracks within the laminate.

Abstract: A wheelchair system includes one or more servers. A software application is provided by the server(s) to be installed on a computing device (such as a mobile phone) communicatively coupled with the server(s) through a telecommunications network. One or more user interfaces displayed on the computing device, using the software application, include a traffic navigation selector configured to receive a user selection indicating that a wheelchair operator is preparing to cross a street. In response to a selection of the traffic navigation selector the software application may: determine whether vehicles are nearby; notify the wheelchair operator when to cross the street; notify the wheelchair operator how much time is left to cross the street; visually record the wheelchair operator crossing the street; and determine, based on receipt of sensory input from computing device sensors and wheelchair sensors, whether an accident has occurred and, if so, notify emergency personal and family/friends.

Abstract: A wheelchair system includes a chip assembly configured to be coupled with a wheelchair, the chip assembly including a wireless communication chip. The wireless communication chip is programmed to, in response to the chip assembly coming within a predetermined range of a dedicated short range communication (DSRC) device of an automobile, automatically communicate, through a telecommunications network, a notification signal to the DSRC device that the wheelchair is within the predetermined range. The chip assembly includes one or more chips configured to, in response to receiving an acknowledgment signal through the telecommunications network from the DSRC device, provide an acknowledgment notification to a user of the wheelchair that the notification signal was received.

Abstract: A wheelchair system includes a chip assembly configured to be coupled with a wheelchair, the chip assembly including a wireless communication chip. The wireless communication chip is programmed to, in response to the chip assembly coming within a predetermined range of a dedicated short range communication (DSRC) device of an automobile, automatically communicate, through a telecommunications network, a notification signal to the DSRC device that the wheelchair is within the predetermined range. The chip assembly includes one or more chips configured to, in response to receiving an acknowledgment signal through the telecommunications network from the DSRC device, provide an acknowledgment notification to a user of the wheelchair that the notification signal was received.

Abstract: An immunogenic agent which comprises a killed strain of Burkholderia pseudomallei, or a combination of components thereof which combination produces a protective immune response in an animal to whom it is administered, and which comprises at least two members selected from the group consisting of (i) a lipopolysaccharide of Burkholderia pseudomallei, (ii) a capsular polysaccharide of Burkholderia pseudomallei and (iii) a protein of Burkholderia pseudomallei or an immunogenic variant thereof or an immunogenic fragment of either of these, or a nucleic acid which expresses said protein, immunogenic variant or immunogenic fragment thereof in a host animal; for use in the prevention or treatment of infection by Burkholderia pseudomallei and/or Burkholderia mallei.

Abstract: An immunogenic agent which comprises a killed strain of Burkholderia pseudomallei, or a combination of components thereof which combination produces a protective immune response in an animal to whom it is administered, and which comprises at least two members selected from the group consisting of (i) a lipopolysaccharide of Burkholderia pseudomallei, (ii) a capsular polysaccharide of Burkholderia pseudomallei and (iii) a protein of Burkholderia pseudomallei or an immunogenic variant thereof or an immunogenic fragment of either of these, or a nucleic acid which expresses said protein, immunogenic variant or immunogenic fragment thereof in a host animal; for use in the prevention or treatment of infection by Burkholderia pseudomallei and/or Burkholderia mallei.

Abstract: An immunogenic agent which comprises a killed strain of Burkholderia pseudomallei, or a combination of components thereof which combination produces a protective immune response in an animal to whom it is administered, and which comprises at least two members selected from the group consisting of (i) a lipopolysaccharide of Burkholderia pseudomallei, (ii) a capsular polysaccharide of Burkholderia pseudomallei and (iii) a protein of Burkholderia pseudomallei or an immunogenic variant thereof or an immunogenic fragment of either of these, or a nucleic acid which expresses said protein, immunogenic variant or immunogenic fragment thereof in a host animal; for use in the prevention or treatment of infection by Burkholderia pseudomallei and/or Burkholderia mallei.

Abstract: This invention relates to proteins expressed by ABC system genes of Burkholderia pseudomallei. The proteins (or protective fragments or protective variants thereof) are protective against Burkholderia pseudomallei infection. Use of the proteins in treating Burkholderia mallei or Burkholderia pseudomallei infection and uses in the preparation of vaccines against melioidosis and glanders are described and claimed.

Abstract: An immunogenic agent which comprises a killed strain of Burkholderia pseudomallei, or a combination of components thereof which combination produces a protective immune response in an animal to whom it is administered, and which comprises at least two members selected from the group consisting of (i) a lipopolysaccharide of Burkholderia pseudomallei, (ii) a capsular polysaccharide of Burkholderia pseudomallei and (iii) a protein of Burkholderia pseudomallei or an immunogenic variant thereof or an immunogenic fragment of either of these, or a nucleic acid which expresses said protein, immunogenic variant or immunogenic fragment thereof in a host animal; for use in the prevention or treatment of infection by Burkholderia pseudomallei and/or Burkholderia mallei.

Abstract: A method for making an electronic module includes forming a low temperature co-fired ceramic (LTCC) substrate with at least one capacitive structure embedded therein. Forming the LTCC substrate may include arranging first and second unsintered ceramic layers and the at least one capacitive structure therebetween. The at least one capacitive structure may include a pair of electrode layers, an inner dielectric layer between the pair of electrode layers, and at least one outer dielectric layer adjacent at least one of the electrode layers and opposite the inner dielectric layer. The at least one outer dielectric layer preferably has a dielectric constant less than a dielectric constant of the inner dielectric layer. The unsintered ceramic layers and the at least one capacitive structure may also be heated, and at least one electronic device may be mounted on the LTCC substrate and electrically connected to the at least one embedded capacitive structure.

Abstract: The EASYRECEIPT device stores, organizes and files paper receipts electronically to be uploaded to accounting and tax preparation software. EASYRECEIPT is capable of storing receipts up to four inches wide and any length in memory. Receipts too wide for the device can be entered manually using the alphanumeric indicators. The device allows the categorization of receipts based on user preferences. Difficult to read receipts can be magnified on display screen and reproduced in larger type size than the original. Users select the actions to perform through a menu of options visible on the display screen. There is a slide-out bin on the side for hard-copy storage.

Abstract: This invention discloses methods, compositions and kits for the detection of extremely low levels of nucleic acid, cells and cellular material in biological samples. The nucleic acid detection systems utilize either the pyrophosphorolysis reaction catalyzed by various polymerases or nuclease digestion coupled with pyrophosphorylation catalyzed by phosphoribosylpyrophosphate synthetase to produce either deoxyribonucleoside triphosphates or ribonucleoside triphosphates. dNTPs are transformed to ATP by the action of nucleoside diphosphate kinase. The ATP produced by these reactions may be detected by luciferase or NADH based detection systems. If more sensitive detection is required, schemes for the amplification of NTPs and dNTPS are provided. A detection system for cells or cellular material in a sample is provided wherein AMP and a high energy phosphate donor added to a sample are converted to ATP by the action of endogenous enzymes, followed by detection of the ATP.

Abstract: This invention discloses methods, compositions and kits for the detection of extremely low levels of nucleic acid, cells and cellular material in biological samples. The nucleic acid detection systems utilize either the pyrophosphorolysis reaction catalyzed by various polymerases or nuclease digestion coupled with pyrophosphorylation catalyzed by phosphoribosylpyrophosphate synthetase to produce either deoxyribonucleoside triphosphates or ribonucleoside triphosphates. dNTPs are transformed to ATP by the action of nucleoside diphosphate kinase. The ATP produced by these reactions may be detected by luciferase or NADH based detection systems. If more sensitive detection is required, schemes for the amplification of NTPs and dNTPS are provided. A detection system for cells or cellular material in a sample is provided wherein AMP and a high energy phosphate donor added to a sample are converted to ATP by the action of endogenous enzymes, followed by detection of the ATP.